ErbB receptors and cell polarity: New pathways and paradigms for understanding cell migration and invasion

Experimental Cell Research

Volumn 315, Issue 4, 2009, Pages 707-716

  Feigin, Michael E ^a   Muthuswamya, Senthil K ^a,b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell architecture; Cell polarity; ErbB; Invasion; Metastasis; Migration; Signaling

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL; CELL MOTION; CELL POLARITY; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CELL POLARITY; HUMANS; NEOPLASMS; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 62649114637     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.10.034     Document Type: Review

References (119)

1. M.M. Moasser, The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis, Oncogene 26 (2007) 6469-6487.
2. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, W.L. McGuire, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science 235 (1987) 177-182.
3. D.J. Slamon, W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, D.E. Keith, W.J. Levin, S.G. Stuart, J. Udove, A. Ullrich, Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science 244 (1989) 707-712.
4. M. Kobayashi, A. Iwamatsu, A. Shinohara-Kanda, S. Ihara, Y. Fukui, Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas, Oncogene 22 (2003) 1294-1301.
5. T. Holbro, G. Civenni, N.E. Hynes, The ErbB receptors and their role in cancer progression, Exp. Cell Res. 284 (2003) 99-110.
6. L.N. Klapper, M.H. Kirschbaum, M. Sela, Y. Yarden, Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors, Adv. Cancer Res. 77 (2000) 25-79.
7. M.A. Olayioye, R.M. Neve, H.A. Lane, N.E. Hynes, The ErbB signaling network: receptor heterodimerization in development and cancer, EMBO J. 19 (2000) 3159-3167.
8. W.E. Holmes, M.X. Sliwkowski, R.W. Akita,W.J. Henzel, J. Lee, J.W. Park, D. Yansura, N. Abadi, H. Raab, G.D. Lewis, Identification of heregulin, a specific activator of p185erbB2, Science 256 (1992) 1205-1210.
9. R. Lupu, R. Colomer, B. Kannan, M.E. Lippman, Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2287-2291.
10. K.L. Carraway III, M.X. Sliwkowski, R. Akita, J.V. Platko, P.M. Guy, A. Nuijens, A.J. Diamonti, R.L. Vandlen, L.C. Cantley, R.A. Cerione, The erbB3 gene product is a receptor for heregulin, J. Biol. Chem. 269 (1994) 14303-14306.
11. D. Graus-Porta, R.R. Beerli, J.M. Daly, N.E. Hynes, ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling, EMBO J. 16 (1997) 1647-1655.
12. E. Tzahar, H. Waterman, X. Chen, G. Levkowitz, D. Karunagaran, S. Lavi, B.J. Ratzkin, Y. Yarden, A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor, Mol. Cell. Biol. 16 (1996) 5276-5287.
13. H.S. Cho, K. Mason, K.X. Ramyar, A.M. Stanley, S.B. Gabelli, D.W. Denney Jr., D.J. Leahy, Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab, Nature 421 (2003) 756-760.
14. S.L. Sierke, K. Cheng, H.H. Kim, J.G. Koland, Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein, Biochem. J. 322 (Pt. 3) (1997) 757-763.
15. I. Alroy, Y. Yarden, The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions, FEBS Lett. 410 (1997) 83-86.
16. J.C. Feldner, B.H. Brandt, Cancer cell motility-on the road from c-erbB-2 receptor steered signaling to actin reorganization, Exp. Cell Res. 272 (2002) 93-108.
17. Y. Yarden, M.X. Sliwkowski, Untangling the ErbB signalling network, Nat. Rev. Mol. Cell Biol. 2 (2001) 127-137.
18. Y.H. Xu, N. Richert, S. Ito, G.T. Merlino, I. Pastan, Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines, Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 7308-7312.
19. A. Ullrich, L. Coussens, J.S. Hayflick, T.J. Dull, A. Gray, A.W. Tam, J. Lee, Y. Yarden, T.A. Libermann, J. Schlessinger, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells, Nature 309 (1984) 418-425.
20. Y.H. Xu, S. Ishii, A.J. Clark, M. Sullivan, R.K. Wilson, D.P. Ma, B.A. Roe, G.T. Merlino, I. Pastan, Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells, Nature 309 (1984) 806-810.
21. G.T. Merlino, Y.H. Xu, S. Ishii, A.J. Clark, K. Semba, K. Toyoshima, T. Yamamoto, I. Pastan, Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells, Science 224 (1984) 417-419.
22. C.R. Lin, W.S. Chen, W. Kruiger, L.S. Stolarsky, W. Weber, R.M. Evans, I.M. Verma, G.N. Gill, M.G. Rosenfeld, Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells, Science 224 (1984) 843-848.
23. T.A. Libermann, H.R. Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M.D. Waterfield, A. Ullrich, J. Schlessinger, Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin, Nature 313 (1985) 144-147.
24. I.E. Garcia de Palazzo, G.P. Adams, P. Sundareshan, A.J.Wong, J.R. Testa, D.D. Bigner, L.M.Weiner, Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas, Cancer Res. 53 (1993) 3217-3220.
25. D.K. Moscatello, M. Holgado-Madruga, A.K. Godwin, G. Ramirez, G. Gunn, P.W. Zoltick, J.A. Biegel, R.L. Hayes, A.J. Wong, Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors, Cancer Res. 55 (1995) 5536-5539.
26. E.T. Hsieh, F.A. Shepherd, M.S. Tsao, Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinoma, Lung Cancer 29 (2000) 151-157.
27. D. Seth, K. Shaw, J. Jazayeri, P.J. Leedman, Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells, Br. J. Cancer 80 (1999) 657-669.
28. Y.C. Cai, Z. Jiang, F. Vittimberga, X. Xu, L. Savas, B. Woda, M. Callery, B. Banner, Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours, Virchows Arch. 435 (1999) 112-115.
29. F. Ciardiello, G. Tortora, EGFR antagonists in cancer treatment, N. Engl. J. Med. 358 (2008) 1160-1174.
30. C. Shih, L.C. Padhy, M. Murray, R.A. Weinberg, Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts, Nature 290 (1981) 261-264.
31. A.L. Schechter, D.F. Stern, L. Vaidyanathan, S.J. Decker, J.A. Drebin, M.I. Greene, R.A. Weinberg, The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen, Nature 312 (1984) 513-516.
32. A.L. Schechter, M.C. Hung, L. Vaidyanathan, R.A. Weinberg, T.L. Yang-Feng, U. Francke, A. Ullrich, L. Coussens, The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor, Science 229 (1985) 976-978.
33. C.R. King, M.H. Kraus, S.A. Aaronson, Amplification of a novel v-erbB-related gene in a human mammary carcinoma, Science 229 (1985) 974-976.
34. A.C. Hsieh, M.M. Moasser, Targeting HER proteins in cancer therapy and the role of the non-target HER3, Br. J. Cancer 97 (2007) 453-457.
35. W.J. Muller, E. Sinn, P.K. Pattengale, R. Wallace, P. Leder, Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene, Cell 54 (1988) 105-115.
36. L. Bouchard, L. Lamarre, P.J. Tremblay, P. Jolicoeur, Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene, Cell 57 (1989) 931-936.
37. C.T. Guy, M.A. Webster, M. Schaller, T.J. Parsons, R.D. Cardiff, W.J. Muller, Expression of the neu protooncogene in the mammaryepithelium of transgenic mice induces metastatic disease, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10578-10582.
38. P.M. Siegel, D.L. Dankort, W.R. Hardy, W.J. Muller, Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors, Mol. Cell. Biol. 14 (1994) 7068-7077.
39. S.K. Muthuswamy, D. Li, S. Lelievre, M.J. Bissell, J.S. Brugge, ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini, Nat. Cell Biol. 3 (2001) 785-792.
40. E. Liu, A. Thor, M. He, M. Barcos, B.M. Ljung, C. Benz, The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast, Oncogene 7 (1992) 1027-1032.
41. J. Blay, K.D. Brown, Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells, J. Cell. Physiol. 124 (1985) 107-112.
42. Y. Barrandon, H. Green, Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor, Cell 50 (1987) 1131-1137.
43. J.T. Price, H.M. Wilson, N.E. Haites, Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704, Eur. J. Cancer 32A (1996) 1977-1982.
44. A. El-Obeid, E. Bongcam-Rudloff, M. Sorby, A. Ostman, M. Nister, B. Westermark, Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro, Cancer Res. 57 (1997) 5598-5604.
45. F.J. Xu, S. Stack, C. Boyer, K. OBriant, R. Whitaker, G.B. Mills, Y.H. Yu, R.C. Bast Jr., Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis, Clin. Cancer Res. 3 (1997) 1629-1634.
46. T. Turner, P. Chen, L.J. Goodly, A. Wells, EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells, Clin. Exp. Metastasis 14 (1996) 409-418.
47. C.J. Bruns, C.C. Solorzano, M.T. Harbison, S. Ozawa, R. Tsan, D. Fan, J. Abbruzzese, P. Traxler, E. Buchdunger, R. Radinsky, I.J. Fidler, Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma, Cancer Res. 60 (2000) 2926-2935.
48. C. Xue, J. Wyckoff, F. Liang, M. Sidani, S. Violini, K.L. Tsai, Z.Y. Zhang, E. Sahai, J. Condeelis, J.E. Segall, Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis, Cancer Res. 66 (2006) 192-197.
49. C. Xue, F. Liang, R. Mahmood, M. Vuolo, J. Wyckoff, H. Qian, K.L. Tsai, M. Kim, J. Locker, Z.Y. Zhang, J.E. Segall, ErbB3-dependent motility and intravasation in breast cancer metastasis, Cancer Res. 66 (2006) 1418-1426.
50. J.C. den Hartigh, P.M. van Bergen en Henegouwen, A.J. Verkleij, J. Boonstra, The EGF receptor is an actin-binding protein, J. Cell Biol. 119 (1992) 349-355.
51. P.J. Goldschmidt-Clermont, J.W. Kim, L.M. Machesky, S.G. Rhee, T.D. Pollard, Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation, Science 251 (1991) 1231-1233.
52. P. Chen, H. Xie, M.C. Sekar, K. Gupta, A. Wells, Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement, J. Cell Biol. 127 (1994) 847-857.
53. J. Kassis, J. Moellinger, H. Lo, N.M. Greenberg, H.G. Kim, A.Wells, A role for phospholipase C-gamma-mediated signaling in tumor cell invasion, Clin. Cancer Res. 5 (1999) 2251-2260.
54. L. Zhan, B. Xiang, S.K. Muthuswamy, Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors, Cancer Res. 66 (2006) 5201-5208.
55. P. Chen, J.E. Murphy-Ullrich, A. Wells, A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility, J. Cell Biol. 134 (1996) 689-698.
56. A.Y. Chan, S. Raft, M. Bailly, J.B. Wyckoff, J.E. Segall, J.S. Condeelis, EGF stimulates an increase in actin nucleation and filament number at the leading edge of the lamellipod in mammary adenocarcinoma cells, J. Cell. Sci. 111 (Pt. 2) (1998) 199-211.
57. A.Y. Chan, M. Bailly, N. Zebda, J.E. Segall, J.S. Condeelis, Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion, J. Cell Biol.148 (2000) 531-542.
58. G. Mouneimne, L. Soon, V. DesMarais, M. Sidani, X. Song, S.C. Yip, M. Ghosh, R. Eddy, J.M. Backer, J. Condeelis, Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation, J. Cell Biol. 166 (2004) 697-708.
59. J. van Rheenen, X. Song,W. van Roosmalen, M. Cammer, X. Chen, V. Desmarais, S.C. Yip, J.M. Backer, R.J. Eddy, J.S. Condeelis, EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells, J. Cell Biol. 179 (2007) 1247-1259.
60. T.G. Ram, S.P. Ethier, Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification, Cell Growth Differ. 7 (1996) 551-561.
61. S.C. Yip, M. El-Sibai, S.J. Coniglio, G. Mouneimne, R.J. Eddy, B.E. Drees, P.O. Neilsen, S. Goswami, M. Symons, J.S. Condeelis, J.M. Backer, The distinct roles of Ras and Rac in PI 3-kinasedependent protrusion during EGF-stimulated cell migration, J. Cell. Sci. 120 (2007) 3138-3146.
62. L. Adam, R. Vadlamudi, S.B. Kondapaka, J. Chernoff, J. Mendelsohn, R. Kumar, Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase, J. Biol. Chem. 273 (1998) 28238-28246.
63. L. Adam, R. Vadlamudi, M. Mandal, J. Chernoff, R. Kumar, Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1, J. Biol. Chem. 275 (2000) 12041-12050.
64. R.K. Vadlamudi, L. Adam, R.A. Wang, M. Mandal, D. Nguyen, A. Sahin, J. Chernoff, M.C. Hung, R. Kumar, Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells, J. Biol. Chem. 275 (2000) 36238-36244.
65. R. Bagheri-Yarmand, R.K. Vadlamudi, R.A. Wang, J. Mendelsohn, R. Kumar, Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis, J. Biol. Chem. 275 (2000) 39451-39457.
66. D.C. Edwards, L.C. Sanders, G.M. Bokoch, G.N. Gill, Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics, Nat. Cell Biol. 1 (1999) 253-259.
67. M.A. Adelsman, J.B. McCarthy, Y. Shimizu, Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase, Mol. Biol. Cell 10 (1999) 2861-2878.
68. R. Marone, V. Cmiljanovic, B. Giese, M.P. Wymann, Targeting phosphoinositide 3-kinase: moving towards therapy, Biochim. Biophys. Acta 1784 (2008) 159-185.
69. J.S. Biscardi, R.C. Ishizawar, C.M. Silva, S.J. Parsons, Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer, Breast Cancer Res. 2 (2000) 203-210.
70. H. Kim, R. Chan, D.L. Dankort, D. Zuo, M. Najoukas, M. Park, W.J. Muller, The c-Src tyrosine kinase associates with the catalyticdomain of ErbB-2: implications for ErbB-2 mediated signaling and transformation, Oncogene 24 (2005) 7599-7607.
71. S.K. Muthuswamy, P.M. Siegel, D.L. Dankort, M.A. Webster, W.J. Muller, Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity, Mol. Cell. Biol. 14 (1994) 735-743.
72. S.K. Muthuswamy, W.J. Muller, Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor, Oncogene 11 (1995) 271-279.
73. W. Mao, R. Irby, D. Coppola, L. Fu, M. Wloch, J. Turner, H. Yu, R. Garcia, R. Jove, T.J. Yeatman, Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential, Oncogene 15 (1997) 3083-3090.
74. M. Tan, P. Li, K.S. Klos, J. Lu, K.H. Lan, Y. Nagata, D. Fang, T. Jing, D. Yu, ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis, Cancer Res. 65 (2005) 1858-1867.
75. M. Dimri, M. Naramura, L. Duan, J. Chen, C. Ortega-Cava, G. Chen, R. Goswami, N. Fernandes, Q. Gao, G.P. Dimri, V. Band, H. Band, Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior, Cancer Res. 67 (2007) 4164-4172.
76. N. Benlimame, Q. He, S. Jie, D. Xiao, Y.J. Xu, M. Loignon, D.D. Schlaepfer, M.A. Alaoui-Jamali, FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion, J. Cell Biol. 171 (2005) 505-516.
77. D.J. Sieg, C.R. Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, C.H. Damsky, D.D. Schlaepfer, FAK integrates growth-factor and integrin signals to promote cell migration, Nat. Cell Biol. 2 (2000) 249-256.
78. G. Kallergi, D. Mavroudis, V. Georgoulias, C. Stournaras, Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells, Mol. Med. 13 (2007) 79-88.
79. M. Tan, P. Li, M. Sun, G. Yin, D. Yu, Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors, Oncogene 25 (2006) 3286-3295.
80. S.E. Seton-Rogers, Y. Lu, L.M. Hines, M. Koundinya, J. LaBaer, S.K. Muthuswamy, J.S. Brugge, Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells, Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1257-1262.
81. R.S. Muraoka, Y. Koh, L.R. Roebuck, M.E. Sanders, D. Brantley-Sieders, A.E. Gorska, H.L. Moses, C.L. Arteaga, Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1, Mol. Cell. Biol. 23 (2003) 8691-8703.
82. Y. Ueda, S. Wang, N. Dumont, J.Y. Yi, Y. Koh, C.L. Arteaga, Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility, J. Biol. Chem. 279 (2004) 24505-24513.
83. J.J. Northey, J. Chmielecki, E. Ngan, C. Russo, M.G. Annis, W.J. Muller, P.M. Siegel, Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion, Mol. Cell. Biol. 28 (2008) 3162-3176.
84. A.J. Ridley, A. Hall, The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors, Cell 70 (1992) 389-399.
85. A.J. Ridley, H.F. Paterson, C.L. Johnston, D. Diekmann, A. Hall, The small GTP-binding protein rac regulates growth factor-induced membrane ruffling, Cell 70 (1992) 401-410.
86. M. El-Sibai, P. Nalbant, H. Pang, R.J. Flinn, C. Sarmiento, F. Macaluso, M. Cammer, J.S. Condeelis, K.M. Hahn, J.M. Backer, Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells, J. Cell. Sci. 120 (2007) 3465-3474.
87. A. Malliri, M. Symons, R.F. Hennigan, A.F. Hurlstone, R.F. Lamb, T. Wheeler, B.W. Ozanne, The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells, J. Cell Biol. 143 (1998) 1087-1099.
88. T. Murai, T. Miyauchi, T. Yanagida, Y. Sako, Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10, Biochem. J. 395 (2006) 65-71.
89. K.M. Woods Ignatoski, N.K. Grewal, S. Markwart, D.L. Livant, S.P. Ethier, p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion, Neoplasia 5 (2003) 128-134.
90. W.J. Nelson, Adaptation of core mechanisms to generate cell polarity, Nature 422 (2003) 766-774.
91. I.G. Macara, Parsing the polarity code, Nat. Rev. Mol. Cell Biol. 5 (2004) 220-231.
92. A. Suzuki, S. Ohno, The PAR-aPKC system: lessons in polarity, J. Cell. Sci. 119 (2006) 979-987.
93. A. Suzuki, M. Hirata, K. Kamimura, R. Maniwa, T. Yamanaka, K. Mizuno, M. Kishikawa, H. Hirose, Y. Amano, N. Izumi, Y. Miwa, S. Ohno, aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity, Curr. Biol. 14 (2004) 1425-1435.
94. M. Elbert, D. Cohen, A. Musch, PAR1b promotes cell-cell adhesion and inhibits dishevelled-mediated transformation of Madin-Darby canine kidney cells, Mol. Biol. Cell 17 (2006) 3345-3355.
95. J.T. Chang, V.R. Palanivel, I. Kinjyo, F. Schambach, A.M. Intlekofer, A. Banerjee, S.A. Longworth, K.E. Vinup, P. Mrass, J. Oliaro, N. Killeen, J.S. Orange, S.M. Russell, W. Weninger, S.L. Reiner, Asymmetric T lymphocyte division in the initiation of adaptive immune responses, Science 315 (2007) 1687-1691.
96. J.N. Murdoch, D.J. Henderson, K. Doudney, C. Gaston-Massuet, H.M. Phillips, C. Paternotte, R. Arkell, P. Stanier, A.J. Copp, Disruption of scribble (Scrb1) causes severe neural tube defects in the circletail mouse, Hum. Mol. Genet. 12 (2003) 87-98.
97. H.M. Phillips, H.J. Rhee, J.N. Murdoch, V. Hildreth, J.D. Peat, R.H. Anderson, A.J. Copp, B. Chaudhry, D.J. Henderson, Disruption of planar cell polarity signaling results in congenital heart defects and cardiomyopathy attributable to early cardiomyocyte disorganization, Circ. Res. 101 (2007) 137-145.
98. D. Bilder, M. Li, N. Perrimon, Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors, Science 289 (2000) 113-116.
99. A.M. Brumby, H.E. Richardson, scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila, EMBO J. 22 (2003) 5769-5779.
100. R.A. Pagliarini, T. Xu, A genetic screen in Drosophila for metastatic behavior, Science 302 (2003) 1227-1231.
101. L.E. Dow, I.A. Elsum, C.L. King, K.M. Kinross, H.E. Richardson, P.O. Humbert, Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling, Oncogene (2008).
102. D. Gardiol, C. Kuhne, B. Glaunsinger, S.S. Lee, R. Javier, L. Banks, Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation, Oncogene 18 (1999) 5487-5496.
103. S. Nakagawa, J.M. Huibregtse, Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase, Mol. Cell. Biol. 20 (2000) 8244-8253.
104. D. Gardiol, A. Zacchi, F. Petrera, G. Stanta, L. Banks, Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression, Int. J. Cancer 119 (2006) 1285-1290.
105. S. Kuphal, S. Wallner, C.C. Schimanski, F. Bataille, P. Hofer, S. Strand, D. Strand, A.K. Bosserhoff, Expression of Hugl-1 isstrongly reduced in malignant melanoma, Oncogene 25 (2006) 103-110.
106. D. Grifoni, F. Garoia, C.C. Schimanski, G. Schmitz, E. Laurenti, P.R. Galle, A. Pession, S. Cavicchi, D. Strand, The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo, Oncogene 23 (2004) 8688-8694.
107. C.C. Schimanski, G. Schmitz, A. Kashyap, A.K. Bosserhoff, F. Bataille, S.C. Schafer, H.A. Lehr, M.R. Berger, P.R. Galle, S. Strand, D. Strand, Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer, Oncogene 24 (2005) 3100-3109.
108. T. Tsuruga, S. Nakagawa, M. Watanabe, S. Takizawa, Y. Matsumoto, K. Nagasaka, K. Sone, H. Hiraike, Y. Miyamoto, O. Hiraike, T. Minaguchi, K. Oda, T. Yasugi, T. Yano, Y. Taketani, Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer, Oncol. Res. 16 (2007) 431-435.
109. V. Aranda, T. Haire, M.E. Nolan, J.P. Calarco, A.Z. Rosenberg, J.P. Fawcett, T. Pawson, S.K. Muthuswamy, Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control, Nat. Cell Biol. 8 (2006) 1235-1245.
110. W. Guo, Y. Pylayeva, A. Pepe, T. Yoshioka, W.J. Muller, G. Inghirami, F.G. Giancotti, Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis, Cell 126 (2006) 489-502.
111. Y. Wang, D. Du, L. Fang, G. Yang, C. Zhang, R. Zeng, A. Ullrich, F. Lottspeich, Z. Chen, Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling, EMBO J. 25 (2006) 5058-5070.
112. T. Muller, A. Choidas, E. Reichmann, A. Ullrich, Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration, J. Biol. Chem. 274 (1999) 10173-10183.
113. Z. Lu, S. Ghosh, Z.Wang, T. Hunter, Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion, Cancer Cell 4 (2003) 499-515.
114. B. Ozdamar, R. Bose, M. Barrios-Rodiles, H.R. Wang, Y. Zhang, J.L. Wrana, Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity, Science 307 (2005) 1603-1609.
115. X.Wang, J. Nie, Q. Zhou,W. Liu, F. Zhu,W. Chen, H. Mao, N. Luo, X. Dong, X. Yu, Downregulation of Par-3 expression and disruption of Par complex integrity by TGF-beta during the process of epithelial to mesenchymal transition in rat proximal epithelial cells, Biochim. Biophys. Acta 1782 (2008) 51-59.
116. S. Etienne-Manneville, A. Hall, Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta, Cell 106 (2001) 489-498.
117. S. Etienne-Manneville, A. Hall, Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity, Nature 421 (2003) 753-756.
118. S. Etienne-Manneville, J.B. Manneville, S. Nicholls, M.A. Ferenczi, A. Hall, Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization, J. Cell Biol. 170 (2005) 895-901.
119. N. Osmani, N. Vitale, J.P. Borg, S. Etienne-Manneville, Scrib controls Cdc42 localization and activity to promote cell polarization during astrocyte migration, Curr. Biol. 16 (2006) 2395-2405.